Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stimulants01:29

Stimulants

1.4K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.4K
Drug Dependence01:17

Drug Dependence

2.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
2.0K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

7.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.1K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.6K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

2.3K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.3K
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.7K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV-related Stigma and Alcohol Involvement Among People with HIV Who Engage in Unhealthy Drinking.

AIDS and behavior·2026
Same author

DUI Detection From Gait Using a Multichannel 1DCNN-Attention-BiLSTM Framework.

IEEE access : practical innovations, open solutions·2025
Same author

Discriminating Between Marijuana and Alcohol Gait Impairments Using Tile CNN With TICA Pooling.

IEEE open journal of engineering in medicine and biology·2025
Same author

Identification of Opioid Medications Among Persons With Opioid Use Disorder and Chronic Pain.

Substance use & addiction journal·2025
Same author

Feasibility of combining tDCS with exercise for increasing physical activity in people with depression.

Frontiers in physiology·2025
Same author

Resting State Functional Connectivity of the Default Mode Network During Opioid Use and Cessation in Treatment-Seeking Persons.

The European journal of neuroscience·2025

Related Experiment Video

Updated: Apr 19, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

26.8K

E-cigarette knowledge, attitudes, and use in opioid dependent smokers.

Michael D Stein1, Celeste M Caviness2, Kristin Grimone2

  • 1Butler Hospital, Providence, Rhode Island; Alpert Medical School of Brown University, Providence, Rhode Island.

Journal of Substance Abuse Treatment
|December 9, 2014
PubMed
Summary

Opioid-dependent smokers frequently use e-cigarettes (electronic cigarettes) for curiosity or to quit nicotine. This vulnerable population shows higher e-cigarette trial and recent use than the general population.

Keywords:
BuprenorphineE-cigarettesMethadoneSmoking

More Related Videos

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

12.3K
A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

9.1K

Related Experiment Videos

Last Updated: Apr 19, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

26.8K
Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

12.3K
A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

9.1K

Area of Science:

  • Addiction Medicine
  • Public Health
  • Tobacco Control

Background:

  • Opioid-dependent individuals exhibit significantly higher smoking rates (3-5x US prevalence).
  • Traditional smoking cessation methods are often ineffective for this population.
  • Novel harm reduction and cessation strategies, like e-cigarettes, are needed.

Purpose of the Study:

  • To assess knowledge, attitudes, and usage of e-cigarettes among opioid-dependent smokers.
  • To understand the role of e-cigarettes as a potential harm reduction and cessation tool in this group.

Main Methods:

  • Survey of 315 opioid-dependent smokers (methadone or buprenorphine treatment).
  • Data collected on e-cigarette awareness, ever tried, past 30-day use, and reasons for use.
  • Sample demographics: 49.7% male, 85.1% non-Latino White.

Main Results:

  • Nearly all participants (98.7%) had heard of e-cigarettes.
  • A high proportion (73.0%) had ever tried e-cigarettes, and 33.8% used them in the past 30 days.
  • Common reasons for use included curiosity (41.4%) and quitting nicotine (26.0%).

Conclusions:

  • Opioid-dependent smokers demonstrate higher e-cigarette trial and use rates compared to general population surveys.
  • E-cigarette utility as a cessation tool requires further research for optimization.
  • E-cigarettes warrant inclusion in smoking cessation discussions for this high-risk population.